Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Buckner

Showing results (221-230 of 255) with videos related to

Pageof 26
Sort By:
Neuro-Oncology Advances|June 6, 2022
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance)Evanthia Galanis, S Keith Anderson, Erin Twohy, et al.
Cancer|July 24, 2001
A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade gliomaJ C Buckner, P J Schomberg, W L McGinnis, et al.
Cancer|July 11, 2019
A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872Evanthia Galanis, S Keith Anderson, Erin L Twohy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2005
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group StudyEvanthia Galanis, Jan C Buckner, Matthew J Maurer, et al.
Neuro-Oncology|December 21, 2014
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057KDaniel J Ma, Evanthia Galanis, S Keith Anderson, et al.
American Journal of Clinical Oncology|December 13, 2002
Randomized, placebo-controlled, phase III surgical adjuvant clinical trial of megestrol acetate (Megace) in selected patients with malignant melanomaSvetomir Markovic, Vera J Suman, Robert J Dalton, et al.
Cancer|February 22, 2002
Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factorJohn H Edmonson, Ivy A Petersen, Thomas C Shives, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancerP A Burch, J K Breen, J C Buckner, et al.
Cancer|August 10, 1999
Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expressionA Perry, R B Jenkins, J R O'Fallon, et al.
Journal of Neuropathology and Experimental Neurology|March 14, 2001
Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and gradingC Giannini, B W Scheithauer, A L Weaver, et al.
Pageof 26

Showing results (221-230 of 255) with videos related to

Sort By:
Pageof 26
Neuro-Oncology Advances|June 6, 2022
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance)Evanthia Galanis, S Keith Anderson, Erin Twohy, et al.
Cancer|July 24, 2001
A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade gliomaJ C Buckner, P J Schomberg, W L McGinnis, et al.
Cancer|July 11, 2019
A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872Evanthia Galanis, S Keith Anderson, Erin L Twohy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2005
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group StudyEvanthia Galanis, Jan C Buckner, Matthew J Maurer, et al.
Neuro-Oncology|December 21, 2014
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057KDaniel J Ma, Evanthia Galanis, S Keith Anderson, et al.
American Journal of Clinical Oncology|December 13, 2002
Randomized, placebo-controlled, phase III surgical adjuvant clinical trial of megestrol acetate (Megace) in selected patients with malignant melanomaSvetomir Markovic, Vera J Suman, Robert J Dalton, et al.
Cancer|February 22, 2002
Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factorJohn H Edmonson, Ivy A Petersen, Thomas C Shives, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancerP A Burch, J K Breen, J C Buckner, et al.
Cancer|August 10, 1999
Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expressionA Perry, R B Jenkins, J R O'Fallon, et al.
Journal of Neuropathology and Experimental Neurology|March 14, 2001
Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and gradingC Giannini, B W Scheithauer, A L Weaver, et al.
Pageof 26